These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 31900392)
1. Conditional control of RNA-guided nucleic acid cleavage and gene editing. Wang SR; Wu LY; Huang HY; Xiong W; Liu J; Wei L; Yin P; Tian T; Zhou X Nat Commun; 2020 Jan; 11(1):91. PubMed ID: 31900392 [TBL] [Abstract][Full Text] [Related]
2. Light-Driven Activation of RNA-Guided Nucleic Acid Cleavage. Wang S; Wei L; Wang JQ; Ji H; Xiong W; Liu J; Yin P; Tian T; Zhou X ACS Chem Biol; 2020 Jun; 15(6):1455-1463. PubMed ID: 32378871 [TBL] [Abstract][Full Text] [Related]
3. Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs. Fu Y; Reyon D; Joung JK Methods Enzymol; 2014; 546():21-45. PubMed ID: 25398334 [TBL] [Abstract][Full Text] [Related]
4. Conditional Control of CRISPR/Cas9 Function. Zhou W; Deiters A Angew Chem Int Ed Engl; 2016 Apr; 55(18):5394-9. PubMed ID: 26996256 [TBL] [Abstract][Full Text] [Related]
5. Small Molecules for Enhancing the Precision and Safety of Genome Editing. Shin S; Jang S; Lim D Molecules; 2022 Sep; 27(19):. PubMed ID: 36234804 [TBL] [Abstract][Full Text] [Related]
6. Optimization of genome editing through CRISPR-Cas9 engineering. Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770 [TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 in Genome Editing and Beyond. Wang H; La Russa M; Qi LS Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843 [TBL] [Abstract][Full Text] [Related]
8. Establishment and application of a CRISPR-Cas12a assisted genome-editing system in Zymomonas mobilis. Shen W; Zhang J; Geng B; Qiu M; Hu M; Yang Q; Bao W; Xiao Y; Zheng Y; Peng W; Zhang G; Ma L; Yang S Microb Cell Fact; 2019 Oct; 18(1):162. PubMed ID: 31581942 [TBL] [Abstract][Full Text] [Related]
9. Exploiting off-targeting in guide-RNAs for CRISPR systems for simultaneous editing of multiple genes. Ferreira R; Gatto F; Nielsen J FEBS Lett; 2017 Oct; 591(20):3288-3295. PubMed ID: 28884816 [TBL] [Abstract][Full Text] [Related]
10. Engineering guide RNA to reduce the off-target effects of CRISPR. Wu J; Yin H J Genet Genomics; 2019 Nov; 46(11):523-529. PubMed ID: 31902584 [TBL] [Abstract][Full Text] [Related]
11. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9. Yang H; Patel DJ Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637 [TBL] [Abstract][Full Text] [Related]
12. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure. Soriano V AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352 [TBL] [Abstract][Full Text] [Related]
13. Target-dependent nickase activities of the CRISPR-Cas nucleases Cpf1 and Cas9. Fu BXH; Smith JD; Fuchs RT; Mabuchi M; Curcuru J; Robb GB; Fire AZ Nat Microbiol; 2019 May; 4(5):888-897. PubMed ID: 30833733 [TBL] [Abstract][Full Text] [Related]
15. Guide RNA engineering for versatile Cas9 functionality. Nowak CM; Lawson S; Zerez M; Bleris L Nucleic Acids Res; 2016 Nov; 44(20):9555-9564. PubMed ID: 27733506 [TBL] [Abstract][Full Text] [Related]
16. Probing the structural dynamics of the CRISPR-Cas9 RNA-guided DNA-cleavage system by coarse-grained modeling. Zheng W Proteins; 2017 Feb; 85(2):342-353. PubMed ID: 27936513 [TBL] [Abstract][Full Text] [Related]